ProQR Therapeutics (PRQR) Net Income (2021 - 2025)
Historic Net Income for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to -$13.2 million.
- ProQR Therapeutics' Net Income fell 3781.35% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.2 million, marking a year-over-year decrease of 6988.18%. This contributed to the annual value of -$30.0 million for FY2024, which is 15.84% down from last year.
- Latest data reveals that ProQR Therapeutics reported Net Income of -$13.2 million as of Q3 2025, which was down 3781.35% from -$13.9 million recorded in Q2 2025.
- Over the past 5 years, ProQR Therapeutics' Net Income peaked at -$3.9 million during Q2 2024, and registered a low of -$20.0 million during Q3 2022.
- Moreover, its 5-year median value for Net Income was -$12.7 million (2022), whereas its average is -$12.7 million.
- Its Net Income has fluctuated over the past 5 years, first soared by 5974.5% in 2023, then tumbled by 25765.03% in 2025.
- Quarter analysis of 5 years shows ProQR Therapeutics' Net Income stood at -$19.8 million in 2021, then skyrocketed by 35.87% to -$12.7 million in 2022, then surged by 46.95% to -$6.7 million in 2023, then plummeted by 59.73% to -$10.8 million in 2024, then decreased by 22.46% to -$13.2 million in 2025.
- Its Net Income was -$13.2 million in Q3 2025, compared to -$13.9 million in Q2 2025 and -$11.4 million in Q1 2025.